Michael G. DeGroote School of Medicine, Department of Medicine and Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON, Canada.
Michael G. DeGroote Initiative for Innovation in Healthcare, McMaster University, Hamilton, ON, Canada.
Hematology Am Soc Hematol Educ Program. 2018 Nov 30;2018(1):561-567. doi: 10.1182/asheducation-2018.1.561.
In this report, we will review the various clinical and laboratory approaches to diagnosing immune thrombocytopenia (ITP), with a focus on its laboratory diagnosis. We will also summarize the results from a number of laboratories that have applied techniques to detect anti-platelet autoantibodies as diagnostic tests for ITP. Although there is considerable variability in methods among laboratories, there is general agreement that platelet autoantibody testing has a high specificity but low sensitivity. This suggests several possibilities: (1) the ideal test for ITP has yet to be developed, (2) current test methods need to be improved, or (3) ITP is the clinical expression of a variety of thrombocytopenic disorders with different underlying mechanisms. Even the clinical diagnosis of ITP is complex, and experienced clinicians do not always agree on whether a particular patient has ITP. Improvements in the diagnostic approach to ITP are necessary to improve the management of this disorder.
在本报告中,我们将回顾诊断免疫性血小板减少症 (ITP) 的各种临床和实验室方法,重点介绍其实验室诊断。我们还将总结一些实验室的结果,这些实验室应用了检测抗血小板自身抗体的技术作为 ITP 的诊断测试。尽管实验室之间的方法存在相当大的差异,但普遍认为血小板自身抗体检测具有很高的特异性但敏感性较低。这提示了几种可能性:(1)用于 ITP 的理想测试尚未开发,(2)当前的测试方法需要改进,或(3)ITP 是具有不同潜在机制的多种血小板减少症疾病的临床表现。即使是 ITP 的临床诊断也很复杂,经验丰富的临床医生并不总是就特定患者是否患有 ITP 达成一致意见。需要改进 ITP 的诊断方法,以改善对这种疾病的管理。